GlycoMimetics Inc.

NASDAQ: GLYC · Real-Time Price · USD
0.25
0.01 (4.60%)
At close: May 15, 2025, 3:59 PM
0.25
0.48%
After-hours: May 15, 2025, 07:27 PM EDT

GlycoMimetics Statistics

Share Statistics

GlycoMimetics has 64.51M shares outstanding. The number of shares has increased by 0.08% in one year.

Shares Outstanding 64.51M
Shares Change (YoY) 0.08%
Shares Change (QoQ) 0.05%
Owned by Institutions (%) 47.07%
Shares Floating n/a
Failed to Deliver (FTD) Shares 777
FTD / Avg. Volume 0.06%

Short Selling Information

The latest short interest is 1.83M, so 2.84% of the outstanding shares have been sold short.

Short Interest 1.83M
Short % of Shares Out 2.84%
Short % of Float 3.44%
Short Ratio (days to cover) 2.75

Valuation Ratios

The PE ratio is -0.42 and the forward PE ratio is -7.94. GlycoMimetics's PEG ratio is -0.25.

PE Ratio -0.42
Forward PE -7.94
PS Ratio 0
Forward PS 1.1
PB Ratio 0
P/FCF Ratio -0.52
PEG Ratio -0.25
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for GlycoMimetics.

EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

Current Ratio 0
Quick Ratio 0
Debt / Equity 0.01
Debt / EBITDA -1.77
Debt / FCF -2.15
Interest Coverage 0

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity n/a
Return on Assets n/a
Return on Invested Capital n/a
Revenue Per Employee n/a
Profits Per Employee $-9,469,789.5
Employee Count 4
Asset Turnover 0
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate 0%

Stock Price Statistics

The stock price has increased by -11.06% in the last 52 weeks. The beta is 1.7, so GlycoMimetics's price volatility has been higher than the market average.

Beta 1.7
52-Week Price Change -11.06%
50-Day Moving Average 0.24
200-Day Moving Average 0.24
Relative Strength Index (RSI) 52.73
Average Volume (20 Days) 1,250,242

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -32.51M
Net Income -37.88M
EBITDA -37.84M
EBIT n/a
Earnings Per Share (EPS) -0.59
Full Income Statement

Balance Sheet

The company has 10.72M in cash and 66.84M in debt, giving a net cash position of -56.12M.

Cash & Cash Equivalents 10.72M
Total Debt 66.84M
Net Cash -56.12M
Retained Earnings -494.36B
Total Assets 11.09M
Working Capital 5.31M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -31.1M and capital expenditures -9.97K, giving a free cash flow of -31.11M.

Operating Cash Flow -31.1M
Capital Expenditures -9.97K
Free Cash Flow -31.11M
FCF Per Share -0.48
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

GLYC does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Payout Ratio n/a
Earnings Yield n/a
FCF Yield n/a
Dividend Details

Analyst Forecast

Currently there are no analyst rating for GLYC.

Price Target n/a
Price Target Difference n/a
Analyst Consensus n/a
Analyst Count n/a
Stock Forecasts

Scores

Altman Z-Score -69.66
Piotroski F-Score 1